1. The FDA approved emergency use of an Ebola rapid antigen fingerstick test for detecting Ebola amid the Democratic Republic of Congo’s current Ebola outbreak.
2. Keytruda, manufactured by Merck, won approval for the treatment of patients with hepatocellular carcinoma, the most common form of liver cancer.
3. Revefenacin, marketed as Yupelri, is a once-daily, long-acting muscarinic antagonist for the maintenance treatment of chronic obstructive pulmonary disease.
4. Medical devicemaker Lumendi secured FDA approval for its DiLumen EIP device modification to help improve tissue retraction during an endoscopy.
More articles on supply chain:
Samsung Galaxy wants to help patients manage insulin therapy
Red Cross issues call for blood donations ahead of holidays
FDA’s cybersecurity policies for postmarket medical devices are ‘insufficient,’ OIG finds
